Alix E. Seif

5.0k total citations · 1 hit paper
122 papers, 3.1k citations indexed

About

Alix E. Seif is a scholar working on Public Health, Environmental and Occupational Health, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Alix E. Seif has authored 122 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Public Health, Environmental and Occupational Health, 47 papers in Oncology and 42 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Alix E. Seif's work include Acute Lymphoblastic Leukemia research (45 papers), Childhood Cancer Survivors' Quality of Life (38 papers) and Neutropenia and Cancer Infections (26 papers). Alix E. Seif is often cited by papers focused on Acute Lymphoblastic Leukemia research (45 papers), Childhood Cancer Survivors' Quality of Life (38 papers) and Neutropenia and Cancer Infections (26 papers). Alix E. Seif collaborates with scholars based in United States, Canada and Spain. Alix E. Seif's co-authors include Stephan A. Grupp, David T. Teachey, Richard Aplenc, Brian T. Fisher, Yimei Li, Susan R. Rheingold, Shannon L. Maude, Yuan‐Shung Huang, David M. Barrett and Rochelle Bagatell and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Alix E. Seif

115 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy

2013 459 citations David T. Teachey, Susan R. Rheingold et al. Blood profile →

Peers

Countries citing papers authored by Alix E. Seif

Since Specialization

Citations

This map shows the geographic impact of Alix E. Seif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alix E. Seif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alix E. Seif more than expected).

Fields of papers citing papers by Alix E. Seif

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alix E. Seif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alix E. Seif. The network helps show where Alix E. Seif may publish in the future.

Co-authorship network of co-authors of Alix E. Seif

This figure shows the co-authorship network connecting the top 25 collaborators of Alix E. Seif. A scholar is included among the top collaborators of Alix E. Seif based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alix E. Seif. Alix E. Seif is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Absolute neutrophil count clinical trial eligibility criteria for pediatric oncology phase I and phase I/II trials by sponsorship 2024 ·Pediatric Blood & Cancer ·Jenny Ruiz, Rebecca K. Kelly, Richard Aplenc, Theodore W. Laetsch, Alix E. Seif	2
2	Isolated central nervous system relapse in two adolescents with primary mediastinal large B‐cell lymphoma after treatment with R‐DA‐EPOCH 2024 ·Pediatric Blood & Cancer ·(unknown), Leslie S. Kersun, Anne F. Reilly, Alix E. Seif, Leena Chehab	0
3	CD4 ⁺ T Cells Mediate Dendritic Cell Licensing to Promote Multi‐Antigen Anti‐Leukemic Immune Response 2024 ·Cancer Medicine ·Luis Gil‐de‐Gómez, (unknown), Jessica H. Lee, Stephan A. Grupp, Gregor S. D. Reid, Alix E. Seif	1
4	Multilevel challenges to equitable inclusion of children in trials when parents use languages other than English: A qualitative report from Children's Oncology Group's Diversity and Health Disparities Committee Language Equity Working Group 2024 ·Pediatric Blood & Cancer ·Sheila Judge Santacroce, Melissa Beauchemin, Wendy Pelletier, (unknown), Jenny Ruiz, Lindsay Blazin, Paula Aristizabal, (unknown), (unknown), Justine M. Kahn, Cassie Kline, Alix E. Seif, María Velez, Lena E. Winestone	2
5	Approach for defining human adenovirus infection and disease for central review adjudication in clinical studies 2024 ·Pediatric Transplantation ·Brian T. Fisher, Jesse Blumenstock, Craig L K Boge, (unknown), Alix E. Seif, Michael Green, Marian G. Michaels, (unknown), Monica I. Ardura, Tamara P. Miller, Diego R. Hijano, William J. Muller, Jennifer E. Schuster, Abby M. Green, Daniel E. Dulek, Adriana E. Kajon, Lara Danziger‐Isakov	1
6	The Eμ-Ret mouse is a novel model of hyperdiploid B-cell acute lymphoblastic leukemia 2024 ·Leukemia ·Ali Farrokhi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sumin Jo, (unknown), (unknown), (unknown), Franziska Auer, Julia Hauer, Stephan A. Grupp, Patrice Eydoux, Philipp F. Lange, Alix E. Seif, Christopher A. Maxwell, Gregor S. D. Reid	2
7	Clinical trial recruitment of people who speak languages other than English: a Children’s Oncology Group report 2024 ·JNCI Cancer Spectrum ·Melissa Beauchemin, (unknown), Sheila Judge Santacroce, (unknown), Jenny Ruiz, (unknown), Justine M. Kahn, Cecilia Fu, (unknown), Grace Clarke Hillyer, (unknown), Wendy Pelletier, (unknown), Lindsay Blazin, Cassie Kline, Alix E. Seif, Paula Aristizabal, Lena E. Winestone, María Velez	4
8	Early-life infection depletes preleukemic cells in a mouse model of hyperdiploid B-cell acute lymphoblastic leukemia 2024 ·Blood ·Ali Farrokhi, (unknown), (unknown), Maryam Aletaha, Ana Márquez, (unknown), (unknown), Sumin Jo, (unknown), K. E. Simmons, Jesús Duque‐Afonso, Michael L. Cleary, Alix E. Seif, Tobias R. Kollmann, Soren Gantt, Gregor S. D. Reid	0
9	Association of the social disorganization index with time to first septic shock event in children with acute myeloid leukemia 2023 ·Cancer ·Jenny Ruiz, Yimei Li, (unknown), Yuan‐Shung Huang, Vicky Tam, Heather Griffis, Lena E. Winestone, Brian T. Fisher, Todd A. Alonzo, Yi‐Cheng Wang, (unknown), E. Anders Kolb, Karen Glanz, Kelly Getz, Richard Aplenc, Alix E. Seif	0
10	BK Polyomavirus (BKPyV) Infects and Injures Endothelium after Pediatric Hematopoietic Cell Transplant (HCT) 2021 ·Transplantation and Cellular Therapy ·Anthony Sabulski, (unknown), Nathan Luebbering, (unknown), Kelly E. Lake, (unknown), (unknown), Sara Szabo, Benjamin L. Laskin, Alix E. Seif, Jason T. Blackard, Assem Ziady, Sonata Jodele, Stella M. Davies	1
11	Identifying relapses and stem cell transplants in pediatric acute lymphoblastic leukemia using administrative data: Capturing national outcomes irrespective of trial enrollment 2020 ·Pediatric Blood & Cancer ·(unknown), Yimei Li, Kelly Getz, Caitlin W. Elgarten, Amanda M. DiNofia, Jennifer J. Wilkes, Lena E. Winestone, Yuan‐Shung Huang, Tamara P. Miller, M. Monica Gramatges, Karen R. Rabin, Brian T. Fisher, Richard Aplenc, Alix E. Seif	1
12	Significance of minimal residual disease in pediatric mixed phenotype acute leukemia: a multicenter cohort study 2020 ·Leukemia ·Matthew J. Oberley, Sunil S. Raikar, Gerald Wertheim, Jemily Malvar, Richard Sposto, Karen R. Rabin, (unknown), Alix E. Seif, (unknown), Reuven J. Schore, (unknown), (unknown), William G. Woods, Maurice R.G. O’Gorman, Etan Orgel	11
13	Immune Reconstitution Following TCRαβ/CD19-Depleted Hematopoietic Cell Transplantation for Hematologic Malignancy in Pediatric Patients 2020 ·Transplantation and Cellular Therapy ·Danielle E. Arnold, (unknown), Alix E. Seif, Jennifer Heimall, Yongping Wang, Dimitri Monos, Stephan A. Grupp, Nancy Bunin	9
14	Unintended consequences of evolution of the Common Terminology Criteria for Adverse Events 2019 ·Pediatric Blood & Cancer ·Tamara P. Miller, Brian T. Fisher, Kelly Getz, (unknown), Hanieh Razzaghi, Alix E. Seif, Rochelle Bagatell, Peter C. Adamson, Richard Aplenc	39
15	Veno-occlusive disease after high-dose busulfan–melphalan in neuroblastoma 2018 ·Bone Marrow Transplantation ·Tal Schechter, Evelio Perez‐Albuerne, Tiffany Lin, Meredith S. Irwin, (unknown), Ami V. Desai, Haydar Frangoul, Gregory A. Yanik, L. Lee Dupuis, David A. Jacobsohn, Morris Kletzel, Mark Ranalli, Sandeep Soni, Alix E. Seif, Stephan A. Grupp, Christopher C. Dvorak	19
16	Bortezomib Inpatient Prescribing Practices in Free-Standing Children's Hospitals in the United States 2016 ·PLoS ONE ·Amanda M. DiNofia, (unknown), Alix E. Seif, Yimei Li, Yuan‐Shung Huang, Rochelle Bagatell, Brian T. Fisher, Richard Aplenc	5
17	Toxicities of busulfan/melphalan versus carboplatin/etoposide/melphalan for high-dose chemotherapy with stem cell rescue for high-risk neuroblastoma 2016 ·Bone Marrow Transplantation ·Ami V. Desai, Mallorie B. Heneghan, (unknown), Nancy Bunin, Stephan A. Grupp, Rochelle Bagatell, Alix E. Seif	32
18	A comparison of discharge strategies after chemotherapy completion in pediatric patients with acute myeloid leukemia: a report from the Children’s Oncology Group 2016 ·Leukemia & lymphoma ·Tamara P. Miller, Kelly Getz, Marko Kavčič, Yimei Li, (unknown), Lillian Sung, Todd A. Alonzo, Robert B. Gerbing, Marla Daves, Terzah M. Horton, Michael A. Pulsipher, Jessica A. Pollard, Rochelle Bagatell, Alix E. Seif, Brian T. Fisher, Alan S. Gamis, Richard Aplenc	12
19	Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy breakdown → 2013 ·Blood ·David T. Teachey, Susan R. Rheingold, Shannon L. Maude, Gerhard Zugmaier, David M. Barrett, Alix E. Seif, Kim E. Nichols, (unknown), Michael Kalos, Robert A. Berg, Julie C. Fitzgerald, Richard Aplenc, Lia Gore, Stephan A. Grupp	459
20	Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome 2009 ·British Journal of Haematology ·David T. Teachey, Robert Greiner, Alix E. Seif, Edward F. Attiyeh, Jack Bleesing, John Choi, Catherine S. Manno, Eric Rappaport, Dirk Schwabe, Cecilia Sheen, Kathleen E. Sullivan, Hongming Zhuang, Daniel S. Wechsler, Stephan A. Grupp	110

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact